DCC-3014
Modify Date: 2025-08-26 09:30:36
DCC-3014 structure
|
Common Name | DCC-3014 | ||
|---|---|---|---|---|
| CAS Number | 1628606-05-2 | Molecular Weight | 431.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H25N7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DCC-3014DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively[1]. |
| Name | DCC-3014 |
|---|
| Description | DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: <0.01 μM (c-FMS/CSF-IR), 0.1-1 μM (c-Kit)[1] |
| In Vitro | DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor with anti-cancer and anti-proliferative activities[1]. |
| References |
| Molecular Formula | C23H25N7O2 |
|---|---|
| Molecular Weight | 431.49 |